Please login to the form below

Not currently logged in
Email:
Password:
PMLiVE Top Pharma List

UCB

The Top Pharma List rankings are compiled from GlobalData's pharmaceutical revenue figures, which are based on prescription medicine sales, including generics drugs. They have been compiled below into an infographic of UCB's 2013 CNS (central nervous system) sales performance.

UCB

CHMP recommends eight new medicines for EU approval

CHMP recommends eight new medicines for EU approval

MorphoSys. The CHMP has also recommended approval of UCB’s Bimzelx (bimekizumab) for the treatment of moderate-to-severe plaque psoriasis, while Genetech’s Byoovis (ranibizumab) also received a positive opinion

Biogen doses first patient in phase 3 systemic lupus erythematosus study

Biogen doses first patient in phase 3 systemic lupus erythematosus study added. In addition to BIIB059, Biogen also has another investigational lupus asset – dapirolizumab pegol – which it is developing in collaboration with UCB.

Finalists 2021

by Ruder Finn. for UCB Biopharma. GlaucomaFest: 'medical edutainment' to celebrate excellence in patient-centered glaucoma care.

New thinking, bold action: building a better future for people living with severe diseases

New thinking, bold action: building a better future for people living with severe diseases How UCB Neurology’s deep understanding of people living with neurological conditions is transforming the patient journey. ... UCB campus in the US. For each of us, 2020 brought new and unprecedented challenges.

Joint COVID-19 trial begins testing drugs from Amgen, UCB and Takeda

Joint COVID-19 trial begins testing drugs from Amgen, UCB and Takeda Trial will test therapeutic candidates in hospitalised COVID-19 patients. The COVID-19 R&D Alliance has enrolled the first patient in a trial testing therapeutic candidates from Amgen, UCB and ... Amgen’s Otezla has already entered the trial, while

1 2 3 4 5 6 7 8 9 10 [ Next 5 results ]

COVID-19 Updates and Daily News

Featured jobs

PMHub

Add my company
Spirit

We find the soul in the science, the humanity in the data, harnessing the power of creativity to deliver medical...

Latest intelligence

JulAug cover image
The Chronicles of Pharma: a creative review of pharma’s journey to omnichannel
Chris Ross conducts a literary-inspired review of pharma’s pursuit of communications excellence...
The key to psoriasis innovation? Dispelling the shadow of the JAK inhibitor
Powerful therapies that can improve skin clarity dominate the psoriasis landscape, so why are most patients stuck in a cycle of ineffective topicals? Fishawack Health explores the market and reveals...
Virtual Speaker Program: A Customer Story
Learn how we helped our client develop a virtual speaker program and roll out a series of regional peer-to-peer education sessions....